Pharmaceutical Executive-10-01-2019

Amid new findings on today’s C-suite mood and approach to digital transformation, experts-in a panel discussion and wider examinations by Pharm Exec editors-explore the intersection of data and technology and the areas that must evolve to meet the digital health demands of tomorrow.

Our quest to make sense of a complex future data ecosystem in pharma.

French independent pharma Servier Group, led by president Olivier Laureau, is uniquely positioned to capitalize on new opportunities for expansion and stay true to its R&D and patient-focused mission.

Corey McCann, president and CEO of Pear Therapeutics, discusses how the prescription digital therapeutics space has evolved in a decade from disruptive concept to an exciting, growing market.

With a growing abundance of clinical and health information now available and achievable, the need for industry to apply common structures and rules to interpret and act on this data is critical.

Coexisting with the DSCSA may hinder new legislative efforts.

Realizing the full potential of enabling technologies such as AI and machine learning in measuring treatment value and outcomes.

In keeping pace with the digital transformation, pharma companies are doing pretty well with data and infrastructure, but a fundamental reshaping of operating models remains the biggest hurdle to moving forward.

While commercial websites can employ analytics to gain better snapshots of their visitors, pharma faces far greater challenges in using technology as a way to track and understand its consumers.

Change in season ushers in a pivotal period for pharma in shaping the direction of EU healthcare.

Lapse spotlights wider actions to ensure data accuracy.

The importance of KOIs in tapping into today’s market mindset.

The key steps to evading automation-fueled data crises.

Click the title above to open the Pharmaceutical Executive October 2019 issue in an interactive PDF format.

After two decades of building a robust healthcare ecosystem, Thailand is seeking to move to the next level-Thailand 4.0-a potential stepping stone in its strategy to initiate a transformative era with a greater embrace of R&D.